
Learn how PADCEV plus pembrolizumab reshapes first-line advanced urothelial cancer care—and how nurses spot and manage serious toxicities early.

Learn how PADCEV plus pembrolizumab reshapes first-line advanced urothelial cancer care—and how nurses spot and manage serious toxicities early.






An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.


Although Stivarga may cause side effects after initial treatment, a dose escalation strategy and the preemptive use of steroid creams may help patients to tolerate the regimen better, while allowing them to capitalize on the agent’s survival benefit.